Tag: Miltenyi Biotec

BERGISCH GLADBACH, August 3, 2017 – A new addition to the well-known product family of cell culture media: With the new NK MACS® Medium, human, Miltenyi Biotec offers a product to improve the cultivation of human natural killer cells, or NK cells as they are called. The biotechnology company from Bergisch Gladbach, already known as a... Read more

BERGISCH GLADBACH, June 14, 2017 – The new MACSprep™ PBMC Isolation Kit, human from Miltenyi Biotec allows the preparation of highly pure peripheral blood mononuclear cells (PBMCs) from human whole blood without density gradient centrifugation in only 25 min. The kit is ideal for the processing of small blood samples. Miltenyi Biotec has developed the... Read more

BERGISCH GLADBACH, April 20, 2017 – MACS® GMP T Cell TransAct™ is a ready-to-use reagent for efficient in vitro activation and expansion of human T cells. Also available in research grade. Cell activation is a prerequisite for the successful genetic engineering of T cells. MACS GMP T Cell TransAct from Miltenyi Biotec – with its unique... Read more

Bergisch Gladbach, 22. November 2016– Once again, the MACS® Academy is offering a comprehensive course program at its locations in Bergisch Gladbach, Germany and San Diego, USA, in 2017 – miltenyibiotec.com/macsacademy. The courses will focus on: Immunology, Stem Cell Research, Cardiology, Neuroscience, and advanced technologies including sample preparation, cell separation and flow cytometry. The MACS® Academy... Read more